← Open Payments lookup

JESSICA SHANTZ: Open Payments

NPI 1790255248 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,617 in 162 payments from 16 companies in 2025. Trend: 2023 $5,310 · 2024 $3,291 · 2025 $3,617

Food & beverage: $3,598Travel & lodging: $10Education: $9
CompanyPaymentsAmount
Axsome Therapeutics, Inc.18$554
Neurocrine BioSciences, Inc.23$412
Otsuka America Pharmaceutical, Inc.14$411
Alkermes, Inc.16$324
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$317
Teva Pharmaceuticals USA, Inc.13$306
E.R. Squibb & Sons, L.L.C.8$286
Vanda Pharmaceuticals Inc.11$272
ABBVIE INC.17$267
Lundbeck LLC11$177

Products named: Auvelity, REXULTI, INGREZZA, CAPLYTA, ARISTADA, COBENFY, FANAPT, VRAYLAR.

Industry payments across MI — which companies pay providers there.